Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after <scp>COVID</scp>‐19 vaccine-Reference-Cited by-同舟云学术

Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID‐19 vaccine

Published:2024-09-04 Issue: Volume: Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Investigation

Author:

Jara‐Palomares Luis¹²^ORCID,Bikdeli Behnood³⁴⁵⁶,Jiménez David²⁷,Muriel Alfonso⁸⁹,Demelo‐Rodríguez Pablo¹⁰^ORCID,Mahé Isabelle¹¹¹²¹³,López‐Núñez Juan José²¹⁴¹⁵¹⁶,Megido Joaquín Alfonso¹⁷,Fernández Jiménez Begoña¹⁸,Monreal Manuel²¹⁹,

Affiliation:

1. Respiratory Department Virgen del Rocio Hospital and Instituto de Biomedicina Sevilla Spain

2. CIBERES Carlos III Health Institute Madrid Spain

3. Cardiovascular Medicine Division, Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA

4. Thrombosis Research Group Brigham and Women's Hospital, Harvard Medical School Boston Massachusetts USA

5. YNHH/Yale Center for Outcomes Research and Evaluation (CORE) New Haven Connecticut USA

6. Cardiovascular Research Foundation (CRF) New York New York USA

7. Respiratory Department Hospital Ramón y Cajal and Universidad de Alcalá (IRYCIS) Madrid Spain

8. Biostatistics Department Ramón y Cajal Hospital and Instituto Ramón y Cajal de Investigacion Sanitaria IRYCIS, CIBERESP Madrid Spain

9. University of Alcala Madrid Spain

10. Department of Internal Medicine Hospital General Universitario Gregorio Marañón Madrid Spain

11. Department of Internal Medicine Hôpital Louis Mourier, Assistance Publique des Hôpitaux de Paris (AP‐HP) Colombes France

12. Université Paris Cité Paris France

13. INSERM UMR‐S‐1140 Paris France

14. Department of Internal Medicine Hospital Germans Trias i Pujol Badalona Barcelona Spain

15. Department of Medicine Universitat Autònoma de Barcelona Badalona Barcelona Spain

16. Institut de Recerca Germans Trias i Pujol Badalona Barcelona Spain

17. Department of Internal Medicine Hospital Valle del Nalón Langreo, Asturias Spain

18. Department of Hematology Hospital Universitario de Móstoles Móstoles, Madrid Spain

19. Faculty of Health Sciences UCAM – Universidad Católica San Antonio de Murcia Murcia Spain

Funder

Sanofi España

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.14310

Reference12 articles.

1. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy

2. Executive Summary

3. Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry

4. Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19

5. Risk of venous thromboembolism after COVID‐19 vaccination